Consolidated Statements of Operations and Other Comprehensive Loss (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011
REVENUES	$ 150,000		$ 150,000
EXPENSES
Cost of sales	86,725	0	86,725	0
General and administrative	932,872	283,730	2,514,018	712,831
Research and development	187,126	189,688	546,054	778,982
Expense on extension of warrants	0	0	0	0
Depreciation and amortization	9,561	5,390	26,488	15,796
Bad debt expense	0	0	0	0
Total Expenses	1,216,284	478,808	3,173,285	1,507,609
Loss from Operations	(1,066,284)	(478,808)	(3,023,285)	(1,507,609)
OTHER INCOME (EXPENSES)
Gain on sale of subsidiaries	0	0	0	0
Debt forgiveness	0	0	0	0
Non-controlling interest in loss	0	0	0	0
Other income	0	0	0	0
Interest expense	(6,097)	(6,232)	(18,445)	(18,910)
Loss on termination of license agreement	0	0	0	0
Total Other Expenses	(6,097)	(6,232)	(18,445)	(18,910)
LOSS BEFORE EXTRAORDINARY ITEMS	(1,072,381)	(485,040)	(3,041,730)	(1,526,519)
EXTRAORDINARY ITEMS
Debt forgiveness	0	0	0	0
Lawsuit settlement	0	0	0	0
Total Extraordinary Items	0	0	0	0
NET LOSS	(1,072,381)	(485,040)	(3,041,730)	(1,526,519)
OTHER COMPREHENSIVE LOSS
(Loss) gain on foreign currency translation	957	(10,466)	(1,589)	(15,427)
TOTAL COMPREHENSIVE LOSS	$ (1,071,424)	$ (495,506)	$ (3,043,319)	$ (1,541,946)
BASIC LOSS PER SHARE (in Dollars per share)	$ 0.00	$ 0.00	$ (0.01)	$ (0.01)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING (in Shares)	282,697,797	269,632,672	280,103,399	264,562,692